I really don't want to be a doctor

Chapter 367 New Choice
If it was in the previous life, Jing Xiaoran would definitely not let go of the opportunity to study in a combined master's and doctoral degree, and it was a place in these key medical colleges in China.

This is a quota that many people dream of. If it wasn't for what Jing Xiaoran did in Africa, he wouldn't have this opportunity.

The time spent on combined master and doctoral studies is not only shorter than normal, but also more valuable.

But now, in the face of this opportunity of continuous master's and doctoral studies, Jing Xiaoran hesitated.

Even if it is a top hospital or college in the country, he still has to weigh the pros and cons of studying.

In the final analysis, the doctoral degrees of domestic institutions are not based on academic research!On this point, Jing Xiaoran has a deep understanding in his doctoral career in his previous life, and he has the right to speak.

Compared with scientific research, connections and emotional intelligence rank first, followed by scientific research and academics!
If you don't have the ability to network, you can't get a provincial scientific research project, so what can you use to publish SCI papers?Without a thesis, what can I rely on to apply for a project?
How can you get promoted without scientific research projects and papers?
Therefore, Jing Xiaoran is very clear that the greatest role of this doctor is to expand his circle of contacts and communication, and to improve his class level.

If you want to make truly useful academic research, unless you follow some bigwig-level figures, it's all just "watering".

Compared with undergraduates and masters, a doctor's degree is just a more advanced "watering".

Instead of wasting time going to a domestic university to study for a Ph. D., it is better to stay in the Shenzhou laboratory, and maybe be able to develop more things.

And Jing Xiaoran is an exception, he has a lot of knowledge stored in his mind in his previous life, each of which is unimaginable for current scientific researchers.

"Xiao Ran, you are really amazing!"

As the saying goes, beauty is in the eye of the beholder.

What's more, Jing Xiaoran's performance has long surpassed the evildoer of his age.

This is also the first time for Weng Huijin to see that a third-year student can receive an invitation from a top domestic university.

Jing Xiaoran smiled, "I probably won't go."

"Ah?" Weng Huijin was stunned for a while, "You, aren't you going?"

Give up such a great opportunity?
In the eyes of Chinese people, everything is low-grade, only reading is high.

Now there is an opportunity to go directly to the highest degree, Jing Xiaoran actually wants to give up.

Weng Huijin's eyes were full of doubts.

"Well, I'm going to stay in Fancheng." Jing Xiaoran said with a smile.

"Stay, stay in Fancheng?" Weng Huijin said silently, "But Fancheng is only a second-tier city after all. If you can go to Kyoto, then the future development will definitely be very good!"

When Jing Xiaoran heard the words, he couldn't find a good excuse for a while.

Suddenly Weng Huijin raised his head, blushed slightly, looked at Jing Xiaoran and said, "Xiao Ran, don't give up such a good opportunity for me!"

"What?" Jing Xiaoran was stunned for a moment, but did not react.

"I mean, I can find a job and go to Kyoto in the future. You don't need to stay in Fancheng just because of me." Weng Huijin pursed his lips and said, "Your future and your dreams are the most important."

Jing Xiaoran didn't expect that Weng Huijin actually misunderstood what he meant, and he hadn't considered Weng Huijin's factors in his future plans.

But this time, it reminded Jing Xiaoran.

"Sister, don't worry, I will always be with you. But I will not give up my future so stupidly, I have better choices."

Jing Xiaoran is still used to calling Senior Sister Weng Huijin, this title seems to be easier to call out, and also lighter.

"A better choice?" Weng Huijin blinked, trying to search for more schools than Kyoto University and West China Medical College in her mind.

During the conversation, the two had already taken a taxi to the community where Weng Huijin lived.

Just after getting out of the car, Jing Xiaoran received another unexpected call.

Caller ID, Hamer.

That Pfizer senior medical representative.

"Hey, Mr. Jing, I haven't seen you for many years, so don't come here without any problems!"

After picking up the phone, Hamer's bold and broken Chinese came out.

"Mr. Hammer, I haven't seen you for a few years. Your Chinese level has improved a lot." Jing Xiaoran said with a smile.

"Haha, I hired a Huaxia teacher to study for a while."

After some politeness, Hamer got straight to the point.

Jing Xiaoran knew that this businessman would not be able to afford to go to the Three Treasure Hall if he had nothing to do.

"Mr. Jing, I have good news for you." Hammer said, "After two years of clinical trials, the new oral anticoagulant drug has officially passed Phase 4 and has been approved by the FDA. It has also been approved in China. With the approval of the Food and Drug Administration, it can be officially launched!"

FDA, mainly on behalf of the U.S. Food and Drug Administration, is in charge of: the supervision and inspection of food, drugs (including veterinary drugs), medical devices, food additives, cosmetics, animal food and other products. According to regulations, the above products must pass FDA inspection to prove their safety , to be sold on the market.

It took almost two or three years for new oral anticoagulant drugs from the beginning of research and development to the final market launch.

Today, it has successfully passed the approval of FDA and China Food and Drug Administration.

"Then I will congratulate Mr. Hammer in advance." Jing Xiaoran said.

The launch of new oral anticoagulant drugs means continuous revenue generation, and Pfizer has the world's top drug sales system.

Based on the sales of new oral anticoagulant drugs in previous lives, Pfizer's annual revenue exceeds billions of dollars!

"It's all thanks to Mr. Jing. We only have this opportunity thanks to your patent." Hammer's laughter never stopped.

This new oral anticoagulant drug project was successfully led by him. According to the feedback from clinical trials, this drug will definitely sell well!

Anticoagulant drugs are mainly used clinically for patients with non-valvular atrial fibrillation, adult patients undergoing hip or knee replacement surgery to prevent venous thrombosis, and prevent venous thrombosis in adults to reduce the risk of pulmonary embolism.

The biggest risk of atrial fibrillation is the formation of thrombus in the heart. If the thrombus falls off, it will reach the blood vessels in the brain along with the blood circulation, which will block the blood vessels in the brain, causing hemiplegia of the limbs, crooked mouth and other symptoms.

This is what is commonly referred to as "stroke".

The role of anticoagulant drugs is to prevent strokes!

The currently commonly used anticoagulant drug in clinical practice, warfarin, requires regular testing of coagulation function INR (testing once every three to five days in the early stage, and maybe one week, half a month, and then one month or three months later).Because only when the level of INR reaches the standard value, the drug can take effect.

In addition, the drug effect of warfarin is easily affected by food, which may cause the drug effect to increase and cause bleeding, or the drug effect to decrease and lose the effect of preventing "stroke".

Patients who take "warfarin" orally often have bleeding in the mucous membranes of the body because the blood coagulation function has not been tested.

However, the new oral anticoagulant drugs do not need to detect the INR of coagulation function, and the drug effect is stable. It only needs to be taken orally regularly, and the bleeding probability is almost the same as that of warfarin.

From the perspective of pharmacological effects, Jing Xiaoran's "new oral anticoagulant drug" is obviously better than the traditional "warfarin", the patient's compliance is good, and there is no need to worry about the increased risk of bleeding.

The only disadvantage of new oral anticoagulant drugs is that they are expensive!
Warfarin, a box of 60 tablets, only costs 19 yuan.

According to the drug pricing in the previous life, before the new oral anticoagulant drugs entered the medical insurance, a box of 5 pills cost about 200 yuan!
Today, the pricing of new oral anticoagulant drugs must be about the same as in previous lives.

(End of this chapter)